A Study to Compare Caries Detection in the Pediatric Population Between the iTero Element 5D System and Bitewing Radiographs
Launched by HADASSAH MEDICAL ORGANIZATION · Mar 19, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well two different methods can detect dental cavities in children aged 4 to 9 years. The researchers want to compare the iTero Element 5D System, a special imaging device, with traditional bitewing X-rays, which are standard dental pictures taken to check for cavities. The study is being conducted at the Hebrew University in Israel and is currently recruiting participants.
To participate, children should be scheduled for their regular dental care that includes bitewing X-rays and must have had these X-rays done within the last two weeks. However, children with certain conditions, such as epilepsy or specific allergies, cannot take part. Children in the study will have their cavities checked using both methods, and the goal is to see which one is better at finding cavities. This study is important because it could help improve how we detect dental caries (cavities) in young patients, ensuring they receive the best care possible.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ages 4-9 years
- • Subjects scheduled for bilateral BWR as part of their standard of care
- • Subjects with a recent bilateral BWR which were obtained up to 14 days prior to study visit
- Exclusion Criteria:
- • Subjects who have been diagnosed with epilepsy
- • Subjects with a known allergy to latex or plastic
- • Subjects with allergies to any dental or oral health products
- • Subjects who have undergone a dental treatment since the acquisition of the recent bilateral BWR
About Hadassah Medical Organization
Hadassah Medical Organization (HMO) is a leading healthcare institution based in Jerusalem, Israel, renowned for its commitment to advancing medical research and improving patient care. As a prominent clinical trial sponsor, HMO leverages its state-of-the-art facilities and multidisciplinary expertise to conduct innovative research across various therapeutic areas. The organization is dedicated to fostering collaboration between clinical researchers, healthcare professionals, and academic institutions, ensuring the highest standards of ethical practice and scientific rigor. HMO's mission is to translate groundbreaking research into effective treatments, ultimately enhancing health outcomes for diverse populations both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jerusalem, , Israel
Patients applied
Trial Officials
Moti Moskovitz, Prof.
Principal Investigator
Hadassah Medical Center, Faculty of Dental Medicine, Hebrew University of Jerusalem, Israel
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials